MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, VRDN has $789,017K in assets. $153,009K in debts.

Balance Sheets Overview

Current Ratio
1514.80%
Quick Ratio
1514.80%
Debt to Asset Ratio
19.39%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock-Series BPreferre...
    • Others

Balance Sheets
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
176,346 169,647 117,324
Marketable securities
585,835 321,254 446,032
Unbilled revenue
-70,000 -
Prepaid expenses and other current assets
22,563 11,012 15,394
Total current assets
784,744 571,913 578,750
Property and equipment, net
1,130 1,125 1,091
Operating lease right-of-use asset
2,255 2,582 1,977
Other assets
888 1,518 506
Total assets
789,017 577,138 582,324
Current portion of long-term debt
--8,435
Current portion of deferred revenue - related party
--288
Accounts payable
13,313 10,063 8,518
Long-term debt
-20,890 12,353
Accrued liabilities
38,492 40,633 35,344
Total current liabilities
51,805 50,696 52,585
Long-term debt, net
50,436 --
Derivative liability
12,500 --
Liability related to the sale of future revenue, net
36,092 --
Other liabilities
2,176 2,582 2,077
Deferred revenue - related party
--140
Total liabilities
153,009 74,168 67,155
Preferred stock-Series APreferred Stock
61,188 61,188 61,188
Preferred stock-Series BPreferred Stock
70,868 127,697 127,697
Common stock, 0.01 par value 200,000,000 shares authorized 102,458,094 and 101,826,500 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively
1,025 822 817
Additional paid-in capital
1,946,844 1,531,003 1,508,902
Accumulated other comprehensive income (loss)
-558 363 69
Accumulated deficit
-1,443,359 -1,218,103 -1,183,504
Total stockholders equity
636,008 502,970 515,169
Total liabilities and stockholders equity
789,017 577,138 582,324
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$585,835K Cash and cashequivalents$176,346K Prepaid expenses andother current assets$22,563K Total current assets$784,744K Operating leaseright-of-use asset$2,255K Property and equipment,net$1,130K Other assets$888K Total assets$789,017K Total liabilities andstockholders equity$789,017K Total stockholdersequity$636,008K Total liabilities$153,009K Accumulated deficit-$1,443,359K Accumulated othercomprehensive income (loss)-$558K Additional paid-in capital$1,946,844K Total currentliabilities$51,805K Long-term debt, net$50,436K Liability related to thesale of future...$36,092K Derivative liability$12,500K Other liabilities$2,176K Preferred stock-SeriesBPreferred Stock$70,868K Preferred stock-SeriesAPreferred Stock$61,188K Common stock, 0.01 parvalue 200,000,000...$1,025K Accrued liabilities$38,492K Accounts payable$13,313K

Viridian Therapeutics, Inc. DE (VRDN)

Viridian Therapeutics, Inc. DE (VRDN)